Post-Cutoff.com
  1. Home
  2. Timeline
  3. 2025
  4. Generative AI designs new antibiotics that kill…

Generative AI designs new antibiotics that kill drug-resistant gonorrhoea and MRSA

★★★★scienceMITconfidence: high

MIT's Collins lab (Cell, Aug 2025) used generative models to design more than 36 million candidate compounds from scratch. Lead NG1 kills multidrug-resistant Neisseria gonorrhoeae and DN1 kills MRSA, clearing skin infections in mice. Both act on bacterial membranes by novel mechanisms and are structurally unlike any known antibiotic.

Key facts

Science result

Field
medicine / antibiotic design
Problem
Designing entirely new antibiotic chemotypes against resistant bacteria
Result
De novo AI-generated molecules with novel mechanisms, effective against drug-resistant gonorrhoea (in vitro) and MRSA (in mice).
AI system
generative chemistry models (CReM, F-VAE) with GNN property predictors
Human role
Human-led with AI tools: humans synthesised and tested
Verification
Peer-reviewed in Cell; lab-validated
Status
confirmed
Why surprising
The molecules were not found in any library but invented by AI, and they work through mechanisms not seen in existing drugs.

What happened

The team moved from screening existing libraries to generating new molecules, filtering tens of millions of designs down to a few synthesised leads.

Why it matters

It showed generative AI exploring chemical space beyond existing compound libraries for one of medicine's most urgent needs.

Changelog

  • 2026-09-29: created

Related events

  1. Deep learning discovers halicin, a structurally new broad-spectrum antibiotic ★★★★
  2. Genentech's GNEprop screens 1.4 billion virtual compounds and finds 82 new antibacterial hits ★★

Sources (2)

id: 2025-08-14-mit-generative-ai-antibiotics · updated 2026-09-29 · open in the interactive timeline